Consensus statement on circulating biomarkers for advanced prostate cancer.

被引：0
|
作者：
Sumanasuriya, Semini
Omlin, Aurelius Gabriel
Armstrong, Andrew J.
Attard, Gerhardt
Chi, Kim N.
Bevan, Charlotte L.
Waugh, David J.
Ijzerman, Maarten J.
De Laere, Bram
Lolkema, Martijn P.
Lorente, David
Luo, Jun
Mehra, Niven
Olmos, David
Scher, Howard I.
Soule, Howard R.
Stoecklein, Nikolas H.
Terstappen, Leon W. M. M.
De Bono, Johann S.
机构：
[1] Inst Canc Res, Sutton, Surrey, England
[2] Cantonal Hosp St Gallen, St Gallen, Switzerland
[3] Duke Univ, Duke Canc Inst, Durham, NC USA
[4] BC Canc Agcy, Vancouver, BC, Canada
[5] Imperial Coll London, London, England
[6] Queens Univ Belfast, Belfast, Antrim, North Ireland
[7] Univ Twente, Twente, Netherlands
[8] Univ Antwerp, Oncol Res Ctr, Campus Sint Augustinus, Antwerp, Belgium
[9] Univ Med Ctr Utrecht, Utrecht, Netherlands
[10] Servicio Oncologia Medica Hosp Univ La Fe, Valencia, Spain
[11] Johns Hopkins Univ Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA
[12] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands
[13] Spanish Natl Canc Res Ctr, Madrid, Spain
[14] Mem Sloan Kettering Canc Ctr, New York, NY USA
[15] Prostate Canc Fdn, Santa Monica, CA USA
[16] Heinrich Heine Univ Dusseldorf, Univ Hosp, Dusseldorf, Germany
[17] Univ Twente, Enschede, Netherlands
[18] Inst Canc Res & Royal Marsden Hosp, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 06期
关键词：
D O I：
10.1200/JCO.2018.36.6_suppl.299
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
299
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Circulating microRNAs as potential new biomarkers for prostate cancer
    A Sita-Lumsden
    D A Dart
    J Waxman
    C L Bevan
    [J]. British Journal of Cancer, 2013, 108 : 1925 - 1930
  • [32] Circulating microRNAs as potential new biomarkers for prostate cancer
    Sita-Lumsden, A.
    Dart, D. A.
    Waxman, J.
    Bevan, C. L.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 1925 - 1930
  • [33] Circulating biomarkers of neuroendocrine prostate cancer: an unmet challenge
    Rescigno, Pasquale
    Rodrigues, Daniel Nava
    de Bono, Johann S.
    [J]. BJU INTERNATIONAL, 2017, 119 (01) : 3 - 4
  • [34] Serum circulating microRNAs as potential biomarkers for prostate cancer
    Kasomva, Khanmi
    Savarimuthu, Ignacimuthu
    Paulraj, Gabriel Michael
    Sen, Arnab
    Sailo, Stephen
    Ngachan, S., V
    [J]. CANCER RESEARCH, 2017, 77
  • [35] Biomarkers of response to advanced prostate cancer therapy
    Iacovelli, Roberto
    Ciccarese, Chiara
    Schinzari, Giovanni
    Rossi, Ernesto
    Maiorano, Brigida Anna
    Astore, Serena
    D'Angelo, Tatiana
    Cannella, Antonella
    Pirozzoli, Celeste
    Teberino, Maria Anna
    Pierconti, Francesco
    Martini, Maurizio
    Tortora, Giampaolo
    [J]. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (02) : 195 - 205
  • [36] Biomarkers for Treatment Response in Advanced Prostate Cancer
    Asif, Samia
    Teply, Benjamin A.
    [J]. CANCERS, 2021, 13 (22)
  • [37] Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
    Gillessen, Silke
    Attard, Gerhardt
    Beer, Tomasz M.
    Beltran, Himisha
    Bossi, Alberto
    Bristow, Rob
    Carver, Brett
    Castellano, Daniel
    Chung, Byung Ha
    Clarke, Noel
    Daugaard, Gedske
    Davis, Ian D.
    de Bono, Johann
    dos Reis, Rodolfo Borges
    Drake, Charles G.
    Eeles, Ros
    Efstathiou, Eleni
    Evans, Christopher P.
    Fanti, Stefano
    Feng, Felix
    Fizazi, Karim
    Frydenberg, Mark
    Gleave, Martin
    Halabi, Susan
    Heidenreich, Axel
    Higano, Celestia S.
    James, Nicolas
    Kantoff, Philip
    Kellokumpu-Lehtinen, Pirkko-Liisa
    Khauli, Raja B.
    Kramer, Gero
    Logothetis, Chris
    Maluf, Fernando
    Morgans, Alicia K.
    Morris, Michael J.
    Mottet, Nicolas
    Murthy, Vedang
    Oh, William
    Ost, Piet
    Padhani, Anwar R.
    Parker, Chris
    Pritchard, Colin C.
    Roach, Mack
    Rubin, Mark A.
    Ryan, Charles
    Saad, Fred
    Sartor, Oliver
    Scher, Howard
    Sella, Avishay
    Shore, Neal
    [J]. EUROPEAN UROLOGY, 2018, 73 (02) : 178 - 211
  • [38] Management of Patients with Advanced Prostate Cancer: Report from the Advanced Prostate Cancer Consensus Conference 2021
    Gillessen, Silke
    Armstrong, Andrew
    Attard, Gert
    Beer, Tomasz M.
    Beltran, Himisha
    Bjartell, Anders
    Bossi, Alberto
    Briganti, Alberto
    Bristow, Robert G.
    Bulbul, Muhammad
    Caffo, Orazio
    Chi, Kim N.
    Clarke, Caroline S.
    Clarke, Noel
    Davis, Ian D.
    de Bono, Johann S.
    Duran, Ignacio
    Eeles, Ros
    Efstathiou, Eleni
    Efstathiou, Jason
    Ekeke, Onyeanunam Ngozi
    Evans, Christopher P.
    Fanti, Stefano
    Feng, Felix Y.
    Fizazi, Karim
    Frydenberg, Mark
    George, Dan
    Gleave, Martin
    Halabi, Susan
    Heinrich, Daniel
    Higano, Celesta
    Hofman, Michael S.
    Hussain, Maha
    James, Nick
    Jones, Robert
    Kanesvaran, Ravindran
    Khauli, Raja B.
    Klotz, Laurence
    Leibowitz, Raya
    Logothetis, Chris
    Maluf, Fernando
    Millman, Robin
    Morgans, Alicia K.
    Morris, Michael J.
    Mottet, Nicolas
    Mrabti, Hind
    Murphy, Declan G.
    Murthy, Vedang
    Oh, William K.
    Ost, Piet
    [J]. EUROPEAN UROLOGY, 2022, 82 (01) : 115 - 141
  • [39] Developing a consensus statement for psychosocial support in active surveillance for prostate cancer
    Beckmann, Kerri
    Cahill, Declan
    Brown, Christian
    Van Hemelrijck, Mieke
    Kinsella, Netty
    [J]. BJUI COMPASS, 2023, 4 (01): : 104 - 113
  • [40] The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma
    McNeel, Douglas G.
    Bander, Neil H.
    Beer, Tomasz M.
    Drake, Charles G.
    Fong, Lawrence
    Harrelson, Stacey
    Kantoff, Philip W.
    Madan, Ravi A.
    Oh, William K.
    Peace, David J.
    Petrylak, Daniel P.
    Porterfield, Hank
    Sartor, Oliver
    Shore, Neal D.
    Slovin, Susan F.
    Stein, Mark N.
    Vieweg, Johannes
    Gulley, James L.
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2016, 4
12345